Find clinical trials for Acute Myeloid Leukemia (AML) in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Seattle, WA, USA:
The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Overall Survival (OS) in Acute...
Phase 3
Seattle, Washington, United States and 164 other locations
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Seattle, Washington, United States and 23 other locations
and fludarabine, in subjects with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) undergoing allog...
Phase 1
Seattle, Washington, United States and 5 other locations
PK of APG-2575 in combination with Azacitidine in the patients with AML/MPAL or MDS/CMML. The study consists of dose escalation (Part I) and...
Phase 1, Phase 2
Seattle, Washington, United States and 8 other locations
lymphodepleting chemotherapy. The safety of this treatment will be evaluated, and researchers want to learn if NK cells will help in treating acute...
Phase 1
Seattle, Washington, United States and 9 other locations
or young adults with a certain kind of blood cancer (FLT3-ITD AML) might be able to join this study if it has come back after remission or i...
Phase 1, Phase 2
Seattle, Washington, United States and 36 other locations
when co administered with low-dose cytarabine (LDAC) improves overall survival (OS) versus LDAC and placebo, in treatment-naïve patients with acute...
Phase 3
Seattle, Washington, United States and 108 other locations
[GO]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who...
Phase 3
Seattle, Washington, United States and 71 other locations
combination with all-trans retinoic acid (ATRA) in participants with acute myeloid leukemia (AML) who have relaps...
Phase 1
Seattle, Washington, United States and 7 other locations
This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) ...
Phase 3
Seattle, Washington, United States and 222 other locations
Clinical trials
Research sites
Resources
Legal